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ABSTRACT 
 
Dual Wavelength Polarimetry for Glucose Sensing in the Anterior Chamber of the Eye. 
(December 2011) 
Bilal Hameed Malik, B.S., GIK Institute; M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Gerard L. Coté 
 
 
Clinical guidelines dictate that frequent blood glucose monitoring in diabetic 
patients is critical towards proper management of the disease. Although several different 
types of glucose monitors are now commercially available, most of these devices are 
invasive, thereby adversely affecting patient compliance. To this end, optical 
polarimetric glucose sensing through the eye is proposed as a potential noninvasive 
means to aid in the control of diabetes. Arguably, the most critical and limiting factor 
towards successful application of such a technique is the time varying corneal 
birefringence due to eye motion artifact.  
In the first part of this research, we describe a birefringent ocular model along 
with a geometric ray tracing scheme to serve as a tool toward better understanding of the 
cornea’s birefringence properties. The simulations show that index-unmatched coupling 
of light is spatially limited to a smaller range when compared to an index-matched 
situation. Polarimetric measurements on rabbits’ eyes indicate relative agreement 
between the modeled and experimental values of corneal birefringence. In addition, the 
observed rotation in the plane of polarized light for multiple wavelengths demonstrates 
 iv 
the potential for using a dual-wavelength polarimetric approach to overcome the noise 
due to time-varying corneal birefringence. These results ultimately aid in the 
development of an appropriate eye coupling mechanism for in vivo polarimetric glucose 
measurements. 
The latter part of the dissertation focuses on design and development of a dual 
wavelength optical polarimeter. The described system utilizes real-time closed-loop 
feedback based on proportional-integral-derivative (PID) control, which effectively 
reduces the time taken by the system to stabilize while minimizing the effect of motion 
artifact, which appears as a common noise source for both wavelengths. Glucose 
measurements performed in both in vitro and ex vivo conditions demonstrate the 
sensitivity of the current system. Finally, in vivo results in rabbits indicate that dual-
wavelength polarimetry has the potential to noninvasively probe glucose through the 
anterior chamber of the eye. 
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CHAPTER I  
INTRODUCTION 
 
Diabetes Mellitus: Disease and Therapy 
Diabetes mellitus is a chronic disease, which is marked by high levels of blood 
glucose levels resulting from defects in insulin production, insulin action, or both. It 
currently afflicts over 345 million people worldwide, and over 25 million in the United 
States [1, 2]. In the U.S. this disorder, along with its associated complications, is ranked 
as the seventh leading cause of death.  As of 2007, the estimated direct and indirect cost 
of this disease is $174 billion per year [2]. Self-monitoring of blood glucose is 
recommended for diabetic patients as the current standard of care and, since the 
announcement of the Diabetes Control and Complications Trial results, there is now no 
question that intensive management of blood sugars is an effective means to prevent or 
at least slow the progression of diabetic complications such as kidney failure, heart 
disease, gangrene, and blindness [3]. 
The goal of diabetes therapy is to approximate the blood glucose profile of a normal 
individual.  Without regulation, hypoglycemia, a condition in which the blood glucose 
level falls well below normal, may cause the patient to slip into a coma and eventual 
death.  Alternatively, a condition known as hyperglycemia can develop in 
_____________ 
This dissertation follows the style of Biomedical Optics Express. 
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which blood glucose levels can rise considerably above normal levels. If left untreated, 
these abnormally high blood glucose levels may result in long-term complications such 
as an increased risk of coronary artery disease, hypertension, retinopathy, neuropathy, 
and nephropathy [3, 4]. Research indicates that some of these long-term complications 
can be minimized if diabetes is properly treated [4]. Proper treatment includes 
maintaining blood glucose levels near normal levels.  This can only be achieved with 
frequent blood glucose monitoring so that appropriate actions can be taken, such as 
insulin injections, proper diet, or exercise.  
The current commercially available methods of glucose sensing are usually based on 
colorimetric or electrochemical schemes, which are invasive, requiring a finger stick to 
draw blood each time a reading is needed [5]. This approach is both time-consuming, 
painful, raises concerns about blood borne pathogens, and can be embarrassing.  Thus, 
unfortunately, it is frequently difficult to obtain the appropriate motivation and 
dedication on the part of the diabetic patients for them to commit to an intensive 
program of blood sugar monitoring. 
Continuous glucose monitoring (CGM) is now available commercially for use as a 
trending monitor for the management of diabetes.  Recent trials using CGM suggest 
significant improvements in important clinical outcomes such as hemoglobin A1c, time 
spent in the hypo- and hyperglycemic range, and perceived value to physicians and 
patients [6-8]. To this end, several different CGM devices are now commercially 
available [9, 10]. One of the first noninvasive CGM sensors to be approved by Food and 
Drug Administration (FDA) was the GlucoWatch developed by Cygnus and 
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subsequently sold to Animas Technologies, which is currently part of Johnson and 
Johnson. This device utilizes reverse iontophoresis to measure glucose concentration in 
the subcutaneous fluid [9]. Although termed noninvasive, the iontophoretic current 
disrupts the skin surface, and can cause skin irritation. It also takes up to 20 minutes to 
gather enough fluid to make the measurement.  These actually turned out to be major 
drawbacks and the GlucoWatch technology has been withdrawn from commercial 
distribution [9]. Another noninvasive CGM sensor known as PENDRA was released in 
European markets to be used in conjunction with finger stick blood glucose monitor 
[11]. This device employs impedance spectroscopy at the skin surface whereby a small 
AC current induces impedance changes within the skin and underlying tissues, which 
are correlated to glucose concentration. Although initial studies and assessments of the 
device were promising, post-market trials and investigations indicated poor accuracy, 
which ultimately resulted in withdrawal from commercial distribution [11-13]. 
Most of the currently available commercial CGM devices are minimally invasive 
[10]. MiniMed was the first company to obtain FDA approval as a trending monitor for 
a CGM device and was purchased by Medtronic in 2001[9]. Their current CGM system 
called Guardian RT is an amperometric device which provides glucose measurements in 
real-time. The system includes a 3-day sensor that reports glucose measurements every 5 
minutes, and can save the data for a review and analysis. A minimum of two blood 
glucose measurements per day are required for calibration [14]. A similar amperometric 
device is DexCom STS-7 by DexCom, Inc, which received FDA approval in 2007 for 
trending and post analysis, and can be used for up to 7 days [9].  The device was 
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approved to be used with blood glucose strips; hence the users cannot solely rely on the 
DexCom results. Glucose measurements are taken every 5 minutes, and calibration with 
a finger stick blood glucose sensor is required every 12 hours. 
 
 
 
 
 
Figure 1. Picture of FreeStyle Navigator continuous glucose monitoring system. The 
wireless sensor sends glucose readings to the receiver anywhere within a 10-foot range. 
Source: Abbott Laboratories (http://www.freestylenavigator.com/index.htm)  
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The latest CGM to be approved by FDA (in 2008) is the FreeStyle Navigator by 
Abbott Laboratories, shown in Figure 1. This three-electrode amperometric sensor can 
be inserted under skin for up to 5 days, but glucose is not reported until the first 
calibration, 10 hours after sensor insertion [15]. Then it requires to be calibrated three 
more times – 12, 24, and 72 hours after sensor insertion. In this manner, the FreeStyle 
Navigator needs to be calibrated less frequently when compared to the above mentioned 
counterparts (Guardian RT and DexCom STS-7). At any rate, all of the above mentioned 
currently available devices have similar components. The sensors are inserted across the 
skin using a sharp device to make a cut into the skin and the sharp device is then 
retracted leaving the sensor in the skin [9, 10]. The invasiveness of such devices together 
with the requirement of frequent calibrations and frequent replacement is inconvenient, 
uncomfortable and embarrassing for the end user. Development of a noninvasive 
glucose sensor can, therefore, greatly facilitate the management of diabetes. 
       
Noninvasive Glucose Sensing 
In the last few years, there has been much enthusiasm as well as a strong effort by 
several companies and universities to quantify blood chemicals, particularly glucose, 
using various noninvasive optical approaches [16-29]. These include, but are not limited 
to, near-infrared (NIR) spectroscopy [16-19], polarimetry [23, 25, 30], and Raman 
spectroscopy [26, 27, 29]. The NIR scatter, Raman scatter, and NIR absorption 
approaches suffer primarily from a lack of specificity.  The NIR scatter approach is 
especially non-specific to glucose and confounded by changes in indices of refraction 
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since tissue scattering is caused by a variety of substances and organelles which all have 
different refractive indices [31].  In case of NIR absorption spectroscopy, the absorption 
coefficient of glucose in the NIR regime is significantly smaller than that of water due to 
the large difference in their respective concentrations [32]. The weak glucose absorption 
bands not only overlap with the stronger absorption bands of water, but also of fats, and 
other proteins such as hemoglobin.  Both NIR scattering and NIR absorption techniques 
can be confounded by changes in physical and chemical physiological parameters such 
as changes in blood pressure, temperature, body hydration levels and total protein 
concentrations in blood [33]. For instance, hyperglycemia can result in vasodilatation, 
which leads to increase in perfusion [34]. The increase in amount of blood can manifest 
as increase in light absorption and hence can induce errors in prediction of blood glucose 
concentration. Similarly, hyperglycemia can potentially lead to accelerated collagen 
aging [35]. Therefore, light reflected from the skin of a diabetic patient may have 
different level of intensity in comparison to a healthy subject at equal level of blood 
glucose concentration.  
Likewise, the Raman approach is non-specific, lacks good sensitivity, requires high 
powers, and suffers from large background autofluorescence of the tissue in vivo [32]. 
Moreover, glucose has inherently small Raman scattering cross section (5.6 x 10-30 cm2 
molecule-1 sr-1) and hence Raman-based glucose sensors require long acquisition times 
[36].  Although, a study on the use of Raman spectroscopy for quantitative and 
noninvasive measurement of glucose was reported successful, it was indicated that there 
is a need to better understand the scientific basis for the measurement and calibration 
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processes in order to utilize such technique for practical use [27]. For instance, the 
instrument wavenumber and intensity stability is critical towards good performance 
using independent data. Other Raman based techniques such as Raman optical activity 
and Raman difference spectroscopy have also been applied towards glucose sensing, 
however, in both the methods, the resultant difference signals are very small and long 
data acquisition times are required [37, 38].  
Recently, several multivariate calibration methods have emerged as powerful tools to 
complement the spectroscopic techniques [39, 40]. By introducing non-analyte specific 
variance into the calibration models, several factors that degrade the glucose 
measurement accuracy of spectroscopic methods have been identified. These include 
sample variation in absorption and scattering coefficients, tissue autofluorescence, and 
the physiological time lag between blood and interstitial fluid glucose levels [41-45]. 
Several correction schemes have been implemented in order to circumvent these factors. 
Recently proposed models include a mass transfer model based correction scheme that 
explicitly accounts for glucose kinetics [39], and utilization of both partial least squares 
(PLS) and support vector regression (SVR) [40] to substantially improve the prediction 
accuracy of glucose levels.  
 
Polarimetric Glucose Sensing 
In comparison to the aforementioned techniques, which usually probe the interstitial 
fluid and/or blood to ascertain the blood glucose concentration, optical polarimetry has 
the potential to interrogate the anterior chamber of the eye as a glucose sensing site. 
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Polarimetric quantification of glucose is based on the phenomenon of optical activity, 
which is the ability of glucose molecules to rotate the plane of polarization of the 
transmitted linearly polarized light in direct proportion to the concentration of the 
glucose. One of the difficulties associated with utilizing polarimetry for glucose sensing 
in vivo is that most of the biological tissues are optically turbid. Polarimetric sensing of 
glucose in such media thus becomes challenging due to multiple scattering events which 
scrambles the potentially useful information encoded in the state of polarization of the 
reflected or transmitted light. A possible way to overcome these problems is to probe the 
anterior chamber of the eye, since the absorption effects are minimal, loss of polarization 
information due to scattering effects is insignificant, glucose is the principal chiral 
component, and a direct correlation exists between blood glucose concentration and that 
of aqueous humor [46, 47]. 
The first documented use of polarized light to determine sugar concentration dates 
back to the late 1800’s, where it was used for monitoring industrial sugar production 
processes [48]. The application of optical polarimetry towards physiologic glucose 
sensing through the anterior chamber of the eye is more recent and it started with 
Rabinovitch et al. who were the first to apply polarimetry to the aqueous humor of the 
eye in order to ascertain blood glucose concentration [49, 50]. Their design was based on 
an optical feedback system which utilized two Faraday rotators for feedback and 
compensation. Coté et al. developed a polarimetric scheme based on true phase 
measurement, demonstrating the potential for millidegree sensitivity in glucose-doped 
water solutions [51]. Their system employed a rotating linear polarizer as a modulator 
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and a fixed linear polarizer as an analyzer. Goetz et al. investigated a polarimetric 
system which used an integrator as the feedback element and were able to measure 
incremental rotation in a precision rotational mount with microdegree sensitivity [52]. 
King et al. reported a multispectral polarimetric system in order to account for other 
optically active components in the aqueous humor, which was based on modulation and 
compensation via a Pockels cell [53].  Cameron et al. reported a system similar to 
Rabinovitch, with a digital closed-loop controller which significantly enhanced the 
stability and repeatability of the system [20]. Chou et al. investigated an amplitude-based 
optical heterodyne approach which employed a Zeeman laser [54]. In a subsequent work 
by Coté et al., a dual wavelength system was utilized to minimize the effect of optical 
confounders in aqueous humor, and potentially, corneal birefringence coupled with 
motion artifact [55]. They were also able to investigate the glucose transport time delay 
between blood and aqueous humor of the eye and found that the average transport time 
lag was measured to be less than 5 minutes [46]. Ansari et al. proposed a polarimetric 
system which exploited the Brewster’s reflection of circularly polarized light off of 
intra-ocular lens, and were tested the technique on an eye model in vitro [56]. Rawer et 
al. described another Brewster’s angle based approach which employed modulation of 
linearly polarized light in an open-loop system [57, 58]. More recently, Cameron et al. 
reported on development of a real-time polarimetric glucose sensor which utilized a 
dedicated birefringence compensator in order to account for corneal birefringence [23]. 
The aforementioned research indicates that optical polarimetry for monitoring 
glucose concentration in the aqueous humor of the eye as a potential means of assessing 
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blood glucose concentration has promise, but the realization of such an approach has 
been limited by noise from time-varying corneal birefringence due to motion artifact. 
Consequently, modeling the corneal birefringence of the eye can be critically important 
toward the understanding of this noise source, and, ultimately, toward the development 
of a polarimetric glucose monitor. The research presented in this dissertation would 
address the problems associated with corneal birefringence, and the design and 
development of this polarimetric glucose monitoring technology would ultimately 
provide a means for noninvasive measurement of glucose, thereby facilitating increased 
frequency of the measurement, which will allow the diabetic patient to modify their 
insulin/glucose regimen in an effort to repress the long term secondary complications of 
this disease. 
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CHAPTER II  
THEORY 
 
Fundamentals of Light Polarization 
Polarized light is essentially light in which the waves are all vibrating in one fixed 
direction. The electric and magnetic fields associated with the oscillation of these waves 
are perpendicular to the local direction of propagation i.e. the Poynting vector. In this 
manner, the associated electromagnetic fields have two degrees of freedom associated 
with the two directions orthogonal to the direction of propagation. In essence, the state 
of polarization of light refers to the properties of light within this plane perpendicular to 
the Poynting vector. 
The simplest state of polarization to understand is the linearly polarized light 
wherein the transverse electric field oscillates in a single direction or plane as a function 
of both time and space. This state of polarization is usually achieved using a device 
called polarizer which allows transmission of light in a single plane and (theoretically) 
blocking out light that exists in other planes. The light leaving the polarizer is referred to 
as linearly polarized or plane polarized light. 
   
Optical Activity and Polarimetry 
While the discovery of optical activity can be traced back to the French physicist 
Dominique Francois Arago, Louis Pasteur was the first one to realize that molecular 
symmetry is responsible for the phenomenon of optical activity [59], which is the 
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rotation of the plane of linearly polarized light passing through a solution of chiral 
molecules. The remarkable property of chirality is the ability of left-handed and right-
handed molecules to rotate light differently, and plays a fundamental role in the 
chemistry of life. 
The equation describing such interaction of light with an optically active compound 
is given by: 
  C L

             (1) 
where α is the observed rotation, C is the concentration of the optically active sample, 
and L is the sample path length. In this equation, [α] is the specific rotation which is 
dependent on the wavelength (λ), temperature and pH.  The wavelength dependence is 
known as optical rotatory dispersion and is further defined using the modified Drude 
equation for wavelengths away from or between the absorption bands namely [60],  
  2 2
o
o
k


 


        (2) 
where λ is the wavelength of interest, and ko is a rotational constant corresponding to the 
wavelength λo of maximal absorption.  
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Figure 2. Schematic representation of glucose forms in solution. Fisher (linear) and 
Haworth (cyclical) projections. 
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The premise behind the main focus of this research i.e. application of polarimetry for 
glucose sensing, is based on the optically active nature of glucose molecule. Glucose is 
one of the most abundant and important sugars in nature. When dissolved in water, the 
glucose molecule adopts cyclical form(s) as shown in Figure 2. The molecular 
conformation i.e. α-D-glucose and β-D-glucose are optical isomers knows as anomers 
and differ from each other only in the configuration of the chiral center. After the 
dissolution, the conversion between α-D-glucose and β-D-glucose is a dynamic process 
known as mutarotation that continues until a thermodynamic equilibrium is reached 
between the two forms. Individually, the α-D-glucose and β-D-glucose anomers have 
specific rotation of +122.2o and +18.7o, respectively. At equilibrium, the two forms are 
present in the ratio of 36:64 (α:β) with a net specific rotation value of +52.6o. At room 
temperature and near physiologic pH levels, glucose solution usually reaches 
equilibrium in about 4 hours.  
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Figure 3. A basic polarimeter comprised of two crossed polarizers with the sample 
placed in between them. 
 
 
 
One of the commonly used devices to measure the rotation due an optically active 
sample is an optical polarimeter. In its most basic form, it essentially constitutes of two 
polarizers oriented orthogonally, as shown in Figure 3. After passing the first polarizer, 
the beam is linearly polarized in the plane of polarization set by that initial polarizer. The 
second polarizer, known as the analyzer, is usually set at a 90 degree angle with respect 
to the first polarizer. Therefore, in theory, no light is transmitted in this configuration. If 
an optically active sample is introduced in between the two polarizers, it rotates the state 
of linear polarization as it travels through the sample. As indicated in Equation 1, this 
rotation is directly proportional to the concentration of the sample, and the length of the 
sample chamber. Now, the light transmitted through the analyzer is proportional to the 
amount of rotation due to the sample. Consequently, the measured light intensity is a 
 
 
 
Polarizer 
Analyzer 
Sample 
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direct measure of the sample concentration provided the path length and specific rotation 
of the sample is known.   
 
Anterior Chamber of the Eye 
Light enters the eye through the transparent cornea, which also forms the first major 
refractive component of the eye. It provides both structural and functional integrity while 
serving as a barrier between the outer environment and inside of the eye. The space 
between the cornea and the lens tissue constitutes the anterior chamber of the eye which 
is filled with the fluid aqueous humor. As shown in Figure 4, it is formed in a region 
known as ciliary processes, at an average rate of 2-3 μl per minute [61]. Secretion begins 
with active transport of sodium ions into the spaces between the epithelial cells. The 
sodium ions, in turn, pull chloride and bicarbonate ions along with them to maintain 
electrical neutrality. Then all these ions together cause osmosis of water from the 
sublying tissue in to the same epithelial intercellular spaces, and the resulting solution 
washed from the spaces onto the surfaces of the ciliary processes. In addition, several 
nutrients are transported across the epithelium by active transport or facilitated diffusion; 
these include amino acids, ascorbic acid, and glucose. It then flows around the lens 
through the pupil into the anterior chamber. This flow of aqueous humor also generates 
an intraocular pressure, which is necessary for the proper contour and optical properties 
of the imaging optics within the eye. It also nourishes the cornea and the lens, structures 
that must maintain transparency, and thus cannot depend on blood. Ultimately, the 
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aqueous humor leaves the anterior chamber of the eye via passive outflow near the angle 
region.  
 
 
 
Figure 4. Aqueous humor flows continuously in and out of the anterior chamber and 
nourishes nearby tissues. The fluid leaves the chamber at the open angle where the 
cornea and iris meet. The image of the eye shown here is openly available from the 
National Eye Institute website (http://www.nei.nih.gov) 
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Corneal Birefringence 
Birefringence is a property of materials in which atoms are arranged in a regular 
repetitive array. Such an arrangement can make the material optically anisotropic i.e. 
their optical properties, including the refractive index, are different depending on the 
direction of propagation of light, and the material is said to be birefringent [62]. The 
direction with the lower value of refractive index is the fast axis, and the difference 
between the principle refractive indices is a measure of the birefringence, and is usually 
called the birefringence. 
The origination of birefringence in cornea is attributed to the retarder like behavior 
of its collagen lamellae present in the stroma which constitutes more than 90% of the 
cornea [63], as shown in Figure 5. In humans, the stroma is composed of ~200 stacked 
lamellae that lie parallel to the surface of the cornea [64]. Each lamella contains narrow 
and regularly spaced collagen fibrils implanted in a matrix region made up of 
proteoglycans, inorganic salts, and other soluble proteins. The overall effect of these 
individual lamellae manifests as corneal birefringence, and is similar to the mechanism 
of form birefringence [65]. 
 
 19 
 
Figure 5. Cross section of the human cornea. Source: H. Gray, Anatomy of the Human 
Body, 1918. 
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In a healthy eye, the stromal region of the cornea usually scatters less than 10% of 
the normal transmitted light. This is a remarkable characteristic of cornea given the 
relative difference in the refractive index between the collagen fibrils and the 
proteoglycans embedded in the surrounding matrix [66]. One of the proposed 
mechanisms to address this behavior is that corneal transparency is a consequence of a 
lattice arrangement of collagen fibrils within stromal lamellas [67]. Such a scheme 
allows for destructive interference between the light scattered from adjacent fibrils, 
thereby allowing scattered light to propagate only in the forward direction. 
The dependence of corneal transparency on the distribution and size of collagen 
fibrils is also supported by observations made in swollen corneas. When either corneal 
surface barrier, endothelial or epithelial, is damaged, the stroma swells up by taking in 
water. The increase in hydration results in a change in the optimal collagen packing 
inside the stromal matrix, leading to a loss of transmitted light [68]. For a more technical 
and mathematical treatment of this behavior, the reader is referred to the original 
literature [67-70].    
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CHAPTER III  
MODELING OF CORNEAL BIREFRINGENCE
*†
 
 
Introduction  
Several newer technologies for ophthalmic imaging and diagnosis utilize polarized 
light, thereby making the polarization properties of the ocular tissues an important 
consideration. For instance, scanning laser polarimetry measures the change in the state 
of polarization between the incident and reflected beams to measure the birefringence of 
the retinal nerve fiber layer [71]. Optical coherence tomography uses interferometry to 
resolve the depth of scattering structures, which requires similar state of polarization in 
the reference and sample arms to maximize interference signal [72]. Retinal tomography 
performed with a confocal scanning laser ophthalmoscope utilizes polarizers to 
accentuate the reflected light from the retinal surface and reduce the noise due to 
multiply scattered light [73].  In all these aforementioned technologies, unknown and 
uncontrolled changes in the state of polarization can significantly reduce the device 
performance. Therefore, any measurement and delineation of polarization properties in a 
region of eye other than the cornea would require the knowledge and understanding of 
corneal birefringence. To this end, several theoretical and experimental eye models have 
been proposed to deal with the extent of corneal birefringence [74-81]. Stanworth and 
                                                 
* Part of this chapter is reprinted from B. H. Malik, and G. L. Coté, "Modeling the corneal birefringence 
of the eye toward the development of a polarimetric glucose sensor," J. Biomed. Opt. 15, 037012 (2010), 
with kind permission of SPIE.  
† Part of this chapter is reprinted from B. H. Malik, and G. L. Coté, Characterizing dual wavelength 
polarimetry through the eye for monitoring glucose," Biomed. Opt. Express 1, 1247-1258 (2010), with 
kind permission of Optical Society of America. 
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Naylor proposed that the corneal birefringence for light passing normally though the 
cornea is small, but increases rapidly with increasing angle of incidence [74]. Bour and 
Lopes Cardozo proposed a method to measure the retardation as a function of the point 
of incidence on the pupil plane, and observed that corneal retardation has its slow axis 
along the tangent to the cornea and that its magnitude increases with increasing 
eccentricity of the posterior corneal surface [79]. Van Blokland and Verhelst were one of 
the first to explain the polarization properties of the living human eye with a biaxial 
model [76]. They also hypothesized that for incidence at higher eccentricity (i.e. near the 
corneal limbus), a uniaxial model provides good approximation. More recently, 
Knighton et al. mapped the corneal birefringence using scanning laser polarimetry and 
reported that a complete description of the corneal birefringence requires the cornea to 
be treated as a biaxial material [78].      
Most of this aforementioned research has been directed towards characterization of 
polarization properties of the eye with a focus on ophthalmic imaging and diagnosis. 
Hence, the optical paths usually considered are limited to the region in the anterior 
chamber which allow for light to pass through the pupil. The commercially available 
scanning laser polarimeters allow for polarization measurements but are fundamentally 
limited to macular imaging. Several research groups have reported on the behavior of 
birefringence in the peripheral regions of cornea [72, 81, 82]. Misson utilized circular 
polarization biomicroscopy to study the corneal structure and birefringence [82]. 
Jaronski and Kasprzak devised a phase stepping imaging polarimetry technique to 
measure the birefringence of human cornea in vitro, and concluded that corneal 
 23 
birefringence increases monotonically in the direction of the corneal periphery [81, 83]. 
Hitzenberger et al. employed polarization sensitive optical coherence tomography to 
map the distribution of birefringence at the posterior corneal surface [72]. Their results 
indicated that birefringence is low for beams incident normal to the corneal surface, and 
that at oblique angles, measured birefringence increases with deviation from normal 
incidence. These mentioned reports show the behavior of birefringence in the corneal 
periphery, and are similar in that the direction of beam incidence is always taken to be 
normal or near normal to the center of the cornea. We have developed a coupling 
mechanism to index match the eye and allow light to pass across the anterior chamber of 
the eye. Explained in detail later, this setup uses mirrors and an inverted tube filled with 
saline solution as index-matching fluid between air and cornea in order to provide a 
straight path across the anterior chamber with no coupling through the pupil.  
In this chapter, an eye model to investigate the propagation of light and the effect of 
corneal birefringence on the light transmitted through the anterior chamber is presented. 
The developed model considers both index-matched and index-unmatched coupling 
schemes. The knowledge gained from these experiments and modeling can be useful in 
understanding changes in polarized light as it traverses the anterior chamber of the eye 
and will provide a framework for building a coupling system toward the development of 
an optical polarimeter for noninvasive in vivo glucose sensing. 
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Materials and Methods 
All optical modeling and calculations were performed in CODE V (Optical Research 
Associates, Pasadena, CA) optical design software package and MATLAB (The 
MathWorks, Natick, MA). The CODE V software employs a polarization ray tracing 
method to solve for the optical path through the optical system, the details of which have 
been described elsewhere [84]. It has the ability to partition the optical surface into 
rectangular or circular grid like pattern, where the user has the ability to define the 
birefringence parameters i.e. the direction of fast axis and the birefringence (ne–no, 
where ne and no are the extraordinary and ordinary refractive indices, respectively) for 
each individual grid element.  
The physical dimensions and parameters of the anterior chamber of the eye were 
taken from reference [85], in which the corneal surfaces are treated as spherical 
elements. While a more accurate description of an eye model would include corneal 
surfaces to be treated as aspherical surfaces, the focus of this study is to model the 
corneal birefringence and not the exact anatomical dimensions which are important for 
imaging models. Moreover, it has been shown that an asperical representation of the 
corneal surface results in thinner cornea near the limbus when compared to the spherical 
model [86], which results in a smaller optical path through the cornea and, hence, have a 
smaller effective birefringence. Thus, we believe that our spherical eye model represents 
the worst case scenario where the thickness of the cornea in the limbal region is greater 
that of an anatomically accurate eye model. As shown in Figure 6, the anterior and 
posterior sides of the cornea are spheres centered at the optical axis of the eye with radii 
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of 7.7 mm and 6.8 mm, respectively. Corneal thickness at the center is 0.5 mm, 
gradually increasing towards the peripheral region of the corneal surface. The refractive 
indices of cornea and aqueous humor are taken to be 1.376 and 1.336, respectively.  As 
for the medium outside the cornea, we considered two cases: index-matched coupling 
and index-unmatched coupling. 
 
 
 
 
 
Figure 6. Representative dimensions of the human eye model. The lower boundary of the 
anterior chamber indicates the position of the pupil and the lens. 
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A local x-y-z coordinate system is defined at any arbitrary point on the posterior 
corneal surface such that the tangential plane at that point coincides with the x-y plane, 
then the fast axis points in the z- direction, as illustrated in Figure 7. Hence, the electric 
field of a light ray incident normal to the corneal surface only experiences nx and ny. In 
general, not all incident light is normal to the cornea, and therefore, the corresponding 
electric field vector experiences nx, ny and nz. Thus, a biaxial model can better explain 
the corneal birefringence in which each of the principle coordinate axis is associated 
with a different refractive index. However, according to Van Blokland and Verhelst, nz-
ny is about 10 times larger than ny-nx [76]. Therefore, at larger oblique incident angles 
(explained later for our coupling scheme), a large component of the electric field vector 
lies along the z- axis and a uniaxial model will give a good approximation. We modeled 
our eye as a bent uniaxial slab where at each point the fast axis coincides with the 
direction of local normal, and a maximum birefringence of 0.00159 as calculated by Van 
Blokland and Verhelst [76]. 
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Figure 7. Local Cartesian coordinate system at an arbitrary point P on the posterior 
corneal surface. The system is aligned such that the z-axis is coincident with the local 
normal, and the x-y plane represents the tangential plane at the point P. 
 
 
 
Index-matched Coupling of Light 
The environment outside the posterior corneal surface was assumed to be buffered 
aqueous-saline solution (n = 1.33) for index matching. As shown in Figure 8, incident 
light was tangentially coupled to the anterior chamber of the eye. The advantage of using 
an index-matching solution is to minimize the change in the angle of refraction at the 
interface of the aqueous solution and the posterior cornea. The change in the refractive 
index between saline solution and cornea is on the order of 10
-2
. Similarly, the same 
order of difference exists between refractive indices of cornea and aqueous humor, and 
hence the deviation in beam angle on entering and leaving the eye is minimized. 
Moreover, a direct consequence of this reduced refraction is that the output beam shape 
and size are maintained along with negligible change in the beam divergence. 
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Figure 8. Optical path through the anterior chamber of the eye. Note that the beam 
passes effectively straight through the chamber due to the assumption that the eye is 
index matched. 
 
  
 
 
 
 
 
 
 
 
 29 
Due to the curvature of the cornea, the optical path length through the cornea, and 
thereby the retardance, varies greatly depending on both the angle and point of 
incidence. In order to analyze this variation in our eye model, we initially assumed a 
circular 1-mm-diameter light beam at 635-nm wavelength, and later used a 532-nm 
wavelength beam for comparison. As a result, in order to couple the full area of the 
beam, the top most point of incidence was chosen to be 0.5 mm (i.e. the radius of the 
beam) below the interior apex of the cornea. Similarly, the lowest point of incidence was 
chosen to be 0.5 mm above the limbus. The polarization vector of light beam 
propagation model was chosen to be at 45 degrees with the vertical axis. 
 
Index-unmatched Coupling of Light 
The most noteworthy difference in coupling of light through the anterior chamber of 
the eye compared to the index-matched environment is that the incident light must enter 
the eye at a relatively larger glancing angle with respect to the posterior corneal surface, 
as shown in Figure 9. Without any index matching, both the beam position and angle for 
which the light beam of a given diameter and shape can be coupled through the anterior 
chamber are limited. Similar to the case of index matched coupling, we assumed two 
circular beams at two wavelengths (532-nm and 633-nm) with diameter of 1 mm. Both 
the beam position and angle of incidence were varied to explore the behavior of corneal 
birefringence and to find a region of minimal change in its effect, if any.  
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Figure 9. Optical path through the anterior chamber of the eye for unmatched refractive 
indices. The angle of incidence, α, is measured from the horizontal. Note that light has to 
be incident at a relatively glancing angle with respect to the posterior corneal surface in 
order for the beam to exit the anterior chamber through the cornea. There is no visible 
difference (on the current scale) between the optical paths taken by the two beams at 
different wavelengths, and hence, a single beam path is shown. 
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Experimental Setup to Measure the Effect of Corneal Birefringence  
The experimental measurements of the effect of birefringence were performed on 
three New Zealand White (NZW) rabbits’ eyes. All experiments were performed on eyes 
< 4 hours postmortem, and the corneas were visibly transparent before, during, and after 
the polarimetric measurements. The plane of incidence was taken to be along the nasal 
meridian and the point of incidence was at the nasal side of the eye for all instances. As 
illustrated in Figure 10, the optical sources were two lasers: a 633-nm He-Ne module 
(JDS Uniphase Corp., Milpitas, CA) and a 532-nm diode-pumped solid-state laser 
module emitting at 1 mW and 4 mW, respectively. Both beams were made coincident 
using mirrors on flip mounts (Thorlabs, Newton, NJ) and the output light was polarized 
(100,000:1) at 45o by employing a Glan-Thompson linear polarizer (Newport, Irvine, 
CA). The combined beam was then passed through the anterior chamber of the eye. In 
order to change the beam incidence position and angle, the eye stage was mounted on a 
combined translational (Thorlabs, Newton, NJ) and rotational mount (Newport, Irvine, 
CA). The optical train terminated in the input facet of a rotating waveplate-based 
polarimeter (Thorlabs, Newton, NJ) which was connected to a personal computer for 
real-time state-of-polarization measurements. 
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Figure 10. Optical configuration for experimental measurement of corneal birefringence. 
Note that one of the mirrors was placed on a flip mount in order to couple either 
wavelength at a time. 
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Results and Discussion 
Index-matched Coupling of Light 
To analyze the change in major axis for elliptically polarized output light due to the 
corneal birefringence, the beam position was varied from top to bottom of the anterior 
chamber in 0.1-mm-intervals. The glucose concentration in the aqueous humor was 
assumed to be zero and hence it does not contribute to the rotation of light. As shown in 
Figure 11, there is a sharp change in the angle near the apical region and the angle of 
major axis changes by almost 90 degrees across the circular state of polarization. It can 
be seen that the change in the perceived angle of polarization is much smaller for a beam 
position below 1 mm and is minimal around 1.6 mm below the apex of cornea which is 
near the center of the available probing line of incidence. Thus, the effect of corneal 
birefringence can potentially be minimized for a beam incident at roughly 1.6 mm below 
the apex of the eye. This can also be seen in Figure 12 which shows the change in the 
state of polarization as a function of beam position. While the ratio of major-to-minor 
axis of the ellipse changes in the center region around 1.6 mm below the apex of the eye, 
the orientation of major axis stays relatively constant. 
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Figure 11. (a) Angle of major axis of the output beam polarization ellipse as a function 
of distance from the apex of the cornea. Note that after a rapid change in the orientation 
of major axis near the apex, the variation is much smaller for beam positions below 1 
mm. (b) Angle of major axis as a function of distance from apex of cornea—zoom-in 
view of the 1.3-mm to 2.0-mm region. Note that a shift in the beam position from 1.5 to 
1.4 mm produces a net rotation of ~71 millidegrees due to change in corneal 
birefringence. 
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Figure 12. Variation in state of polarization as a function of distance from the corneal 
apex. Note that although the eccentricity of the ellipse varies near the center of the eye, 
the major axis orientation stays relatively unchanged. 
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Apart from change due to birefringence, it is known that the optical path length 
through the aqueous humor of the eye and the glucose concentration itself would also 
change the measured rotation.  Moreover, the path length is a function of beam position 
on the posterior corneal surface and that the glucose could vary across the physiologic 
range.  Therefore, the effect of change in both of these parameters on the rotation should 
be compared to the changes observed due to the effect of corneal birefringence. The 
change in optical path length as a function of the distance from the apex to the limbus is 
plotted in Figure 13a, and then converted to a change in rotation as plotted in Figure 13b 
using equation 1, and assuming a normal 100 mg/dL glucose concentration. The plot in 
Figure 14 shows the change in rotation as a function of glucose concentration across the 
0-600 mg/dL range for a beam position of 1.6 mm below the apex which corresponds to 
optical path length of 8.82 mm. We also took into account the effect of glucose 
concentration dependent change in refractive index and, thereby, on the optical path 
length. The increase in the refractive index of an aqueous solution of glucose with 
increasing glucose concentration is 2.5 x 10-5 /mM glucose (or 1.39 x 10-6 /mg/dL) [87]. 
This amounts to a change in refractive index of 8.34 x 10-4 across the glucose 
concentration range of 0 to 600 mg/dL. Such a small change in refractive index has 
negligible effect on beam path deviation across the physical path length in the anterior 
chamber of the eye. 
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Figure 13. (a) Change in optical path length through the aqueous humor as a function of 
distance from the apex of the cornea, and (b) corresponding net rotation in angle of 
polarization vector as a function of distance from the apex of the cornea. 
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Figure 14. Net rotation in the angle of polarization vector as a function of glucose 
concentration. The point of incidence is taken to be 1.6 mm below the corneal apex, 
which corresponds to an optical path length of 8.82 mm through the aqueous humor. 
 
 
 
It is clear from Figures 13-14 that for any given change in beam position such as that 
due to motion artifact in the eye, the change in net rotation due to corneal birefringence 
is at least an order of magnitude larger than the effect of changes in optical path 
difference and aqueous humor glucose concentration. For instance, as depicted in Figure 
4b, if the laser beam incidence shifts from 1.5 mm to 1.4 mm due to motion artifact, the 
change in the polarization vector due to corneal birefringence would be ~70 
millidegrees. In comparison, the corresponding change in optical path difference 
produces a net rotation of only 0.12 millidegree. Similarly, a change in glucose 
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concentration by ±10mg/dL, which is the current experimental error in glucose 
estimation [20, 25], changes the net rotation of polarization vector by ±0.4 millidegree. 
This analysis clearly demonstrates that even in the most stable region, the time varying 
corneal birefringence is the most significant noise source in the sample and a major 
limitation preventing realization of an optical polarimetric approach to ascertain aqueous 
humor glucose concentrations in vivo. 
 As explained later in chapter 4, a possible method proposed by our group to reduce 
and potentially eliminate the effect of corneal birefringence is to utilize a multispectral 
scheme [25]. This is done by multiple-linear regression (MLR) analysis which is 
analogous to scaled subtraction. By utilizing at least two wavelengths away from or 
between the absorption bands for glucose, MLR can accommodate the contribution of 
birefringence to the total rotation of the state of polarization and equation 2 can be used 
to predict glucose. One of the assumptions for such an analysis is that the motion artifact 
is wavelength relatively independent in the range of motion. To validate this assumption, 
we utilize a second wavelength away from the glucose absorption band at 532 nm and 
examine the perceived angle of polarization axis due to corneal birefringence with 
respect to that of 635 nm wavelength. Figure 15 shows the plot of major axes of 
elliptically polarized output beams at both the wavelengths. It can be seen that after a 
rapid change near the apical region of the eye, the major axes orientations remains 
relatively unchanged and close to each other, especially between 1.4 mm and 1.8 mm. 
This observation leads to two important advantages. Firstly, for any of the two 
wavelengths, coupling of light at just under the center of the cornea leads to minimum 
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change in state of output polarization due to motion artifact. Secondly, the major axis 
orientations of both the wavelengths have similar magnitude, a direct consequence of 
which is that a dual-wavelength optical polarimeter can be utilized to reduce the sample 
noise associated with motion artifact. 
 
 
 
 
Figure 15. Angle of major axes for wavelengths of 635 (solid line) and 532 nm (dashed 
line) as a function of distance from the apex of the cornea. Note that after a rapid change 
in the major axes orientations near the apex, the variation is much smaller for beam 
positions below 1 mm, and is of similar magnitude. 
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Index-unmatched Coupling of Light 
 In the case of index-unmatched coupling of light through the eye, there is a limited 
range of incident angles for which the full width of the beam can be coupled in-and-out 
of the anterior chamber.  Also, regardless of the angle of incidence, there is range of 
beam position (measured as the distance from corneal apex) for which the full beam is 
able to leave the anterior chamber. For the dimensions and beam size used in our model, 
this range of input was calculated to be from 1.6 mm to 2.5 mm below the corneal apex. 
For any possible combination of incident beam position and angle, the output beam is 
divergent. Based on the this information a total of three different beam positions – 1.6 
mm, 2.0 mm, and 2.5 mm below apex – were selected and the possible ranges of 
incident angles for which the full width of the beam can leave the eye were probed. The 
corresponding data values are plotted in Figure 16, which shows that the largest and 
shortest range of incident angles can be attributed to the beam positions of 2.5 mm and 
1.6 mm below the corneal apex, respectively.  
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Figure 16. Angle of major axis of polarization ellipse as a function of angle of incidence 
for beam position at (a) 2.5 mm, (b) 2.0 mm, and (c) 1.6 mm below the corneal apex. . 
Note that the change in the angle of major axis of the output beam (i.e. the y-axis) 
represents the effect of corneal birefringence only. The angles are calculated assuming 
only aqueous humor without glucose or any other optical rotatory components present in 
the anterior chamber of eye. 
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 It should be noted that, although the overall range of major axis angles associated 
with beam positions of 2.5 mm and 2.0 mm show larger deviations in due to corneal 
birefringence, there is a region in which this deviation is minimized but only when larger 
angles of incidence are used. In comparison, the full available range of angles for a beam 
position of 1.6 mm below the apex shows minimal change in perceived major axis angle 
of the polarization vector for smaller incidence angles.  In addition, it can be seen in 
Figures 17b and 17c that for light coupled at beam positions of 2.5 mm and 2.0 mm 
below apex, and at angles which show minimal change in the output beam’s major axis, 
the beam tends to focus more towards the center of the anterior chamber and away from 
the opposite anterior corneal surface. Consequently, the beam at the exit is more 
divergent compared to that of incidence at 1.6 mm (Figure 17a), in which the focal point 
is near to or in the cornea. Therefore, the beam incidence at 1.6 mm below the apex 
would allow for a smaller incident angle and thus relatively less complicated coupling 
when compared to incidence at 2.0 mm and 2.5 mm below the apex. In particular, the 
position of eye with respect to the nasal bone may limit the range of incident angles. For 
instance, if the coupling is performed by placing a mirror in between the eye and the 
nasal bone then it may potentially be simpler to couple light at smaller incident angles. 
Therefore, the beam incidence at 1.6 mm below the apex appears to be the optimal 
position to minimize the effect of both corneal birefringence and the curvature of the eye 
despite a short range of available incident angles. 
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Figure 17. Optical path through the anterior chamber of the eye for beam position and 
angle of incidence at (a) 1.6 mm and 16o, (b) 2.0 mm and 23o, and (c) 2.5 mm and 28o, 
respectively. 
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 It should be noted that even in the most stable range of change of angle of major 
axis, a small change in the incidence angle rotates the output polarization vector by a 
magnitude much larger than that of due to change in optical path length through the 
anterior chamber and/or glucose concentration. For example, as mentioned above, a 
maximum change in optical path length through the aqueous humor contributes to a net 
change of ~2.5 millidegrees in the angle of polarization vector. Similarly, a 10 mg/dL 
change in glucose concentration produces a net change of ~0.4 millidegrees for light at 
633-nm wavelength. In comparison, if the incidence angle changes from 15o to 16o due 
to motion artifact, the rotation in polarization vector due to corneal birefringence is ~200 
millidegrees. This observation demonstrates that time varying corneal birefringence due 
to motion artifact is a major source of noise that needs to be accounted for in order to  
realize polarimetric quantification of glucose in vivo.   
 That being said, in the case of a change in incidence angle due to motion artifact, the 
MLR analysis would benefit from a linear relationship between the change of angle of 
major axes for the two wavelengths as a function of incidence angle. MLR analysis of 
the respective data points in Figure 16c demonstrates a linear relationship with R2- value 
of 0.9999 across the available range of incidence angles. Hence, the rotation in major 
axis of the state of polarization due to a change in angle of incidence can potentially be 
accommodated using MLR analysis, and as a result, this modeling indicates that a dual-
wavelength optical polarimeter can potentially be utilized to reduce the contribution of 
sample noise related with motion artifact. 
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Experimental Measurement of the Effect of Corneal Birefringence 
 To establish the validity of our eye model, experimental measurements were 
performed. Birefringence measurements were performed on NZW rabbits’ eyes (n = 3). 
The angle of incidence was set at approximately 15o with the beam position near or at 
1.6 mm. The output beam casts a coma-like diverging pattern making it complicated to 
collect the full area of the beam without using collection optics. To overcome this 
problem, the detector head of the polarimeter unit was placed very close to the beam 
exiting the corneal surface. The relatively large size of detector head was also useful in 
maximizing beam collection. 
 The measured individual and mean angle of the major axes is plotted as a function of 
wavelength in Figure 18. Overall, the effect of corneal birefringence was observed to be 
somewhat consistent between the three eyes. It should be noted that although the mean 
measured value for 532 nm wavelength agrees with that of our model, the major axis 
angle for 633 nm wavelength showed a slight deviation when compared to the predicted 
value. It should be noted that the alignment to overlap the beams was done manually 
and, as explained below, this small overlap mismatch may be responsible for generating 
this deviation from the modeled values. The relative consistency between eyes can be 
useful towards establishing a general calibration model for a dual wavelength optical 
polarimeter; nonetheless, as long as the difference within an eye is constant this should 
be good enough for compensation of corneal birefringence within that eye.   
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Figure 18. Inter-eye variation of measured angle of major axis of polarization ellipse as a 
function of wavelength. The data points include measurements for three individual eyes 
and their overall average. 
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 The variation in the effect of corneal birefringence as a function of change in the 
angle of incidence within a single eye was measured. Measurements taken at an angle of 
incidence of 15o, 16.5o and 18o, plotted in Figure 19, show the variation in the measured 
angle of the major axis as a function of incidence angle.  It can be seen that there is a 
discrepancy in measured values when compared to the eye model. This can be attributed 
to the differences in the distribution of birefringence in the cornea of rabbits’ and human 
eyes. Such a comparison has been previously reported by Wang and Bettelheim, who 
investigated the corneal birefringence in several species [88]. The maps of birefringence 
isochores in the human eye show highly centro-symmetrical behavior which is similar to 
that of our eye model. In comparison, the birefringence isochore map of the rabbit 
cornea is relatively anisotropic. As a result, even a small deviation from the nasal 
meridian can cause inconsistency between the modeled and experimental observations. It 
was noted, however, that the net difference between the measured values at respective 
wavelengths is relatively unchanged. Thus, the above mentioned MLR analysis can 
potentially account for these changes, consequently, showing the potential of a 
multispectral polarimetric approach towards reducing the effect of corneal birefringence 
and allowing quantification of glucose in the anterior chamber of the eye. 
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Figure 19. Intra-eye variation of measured angle of major axis of polarization ellipse as a 
function of wavelength and angle of incidence. Note that the angle of major axis changes 
significantly with change in angle of incidence, but the net change between the data 
points for respective wavelengths is relatively constant. 
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The variation between the measured values shown in Figures 18 and 19 and values 
generated from the model can also be attributed to experimental limitations such as the 
light beam positioning, which was done manually by visual inspection.  Hence, it is 
possible that the incident spot was not completely coincident with the desired position of 
1.6 mm below the apex and/or at the center with respect to the x-plane. This can have a 
considerable effect on the effective corneal birefringence experienced by the light beam. 
For example, de-centering of 633-nm beam position by a millimeter in our model would 
change the output beam’s angle of major axis by magnitude of ~16o. Specifically, a +1 
mm horizontal change from the center placement changes the major axis angle to -51.4o 
compared to the previous value of -35.2o. This further highlights the significance of time 
varying corneal birefringence due to motion artifact as a noise source, where such a 
small deviation from the theoretically modeled values can lead to a substantial change in 
experimental observations. Moreover, postmortem artifacts like stromal edema and 
corneal autolysis can potentially change the tissue ultrastructure over time thereby 
changing the effective corneal birefringence properties, which may further increase the 
discrepancy between the modeled and measured data.  However, even though the 
absolute values are different for the model versus the experiment, the relative values for 
each wavelength and difference between wavelengths is relatively constant showing the 
potential for the dual wavelength approach to compensate for these changes, which can 
be present due to motion artifact. 
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CHAPTER IV  
POLARIMETRIC GLUCOSE SENSING
‡
 
 
Introduction 
Polarimeters determine the polarization state of a beam of light or some of its 
polarization characteristics, which may vary from simply determining the plane of 
oscillation for a linearly polarized beam, to as complex as the complete polarization 
parameters of an elliptically polarized beam. A polarimeter utilizes a set of polarization 
elements and components places in the path of the light. As mentioned earlier, the most 
basic form of polarimeter consists of essentially two crossed polarizers. Such a simple 
setup is adequate if the optical rotation to be measured is on the orders of several degrees 
i.e. samples with high concentration and/or long path lengths. 
In order to provide very small angle measurements with high measurement 
sensitivity, polarimeters often employ mechanisms to modulate the plane of polarization 
of the incident field about the optical axis. Along with an analyzer, a modulator can be 
used to both switch the polarized intensity between two orientations on a single detector, 
or exchange between two detectors. If the modulation is done rapidly enough, this 
technique can mitigate the effects of noise related to random events and temperature-
dependent drift, which plague low-frequency measurements. 
                                                 
‡ Part of this chapter is reprinted from B. H. Malik, and G. L. Coté, "Real-time, closed-loop dual-
wavelength optical polarimetry for glucose monitoring," J. Biomed. Opt. 15, 017002 (2010), with kind 
permission of SPIE. 
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In earlier designs, polarization modulation for polarimeters was accomplished by 
physical rotation of a polarizer about the optical axis [51] or rotation of a birefringent 
waveplate [89]. Such modulation schemes often tend to employ bulky and complex 
mechanisms which are subject to failure with repeated use. More recent methods utilize 
electro-optic, magneto-optic or photoelastic effects to modulate the state of polarization 
of light [90]. The polarimeter designed for this research employs a magneto-optic 
modulator for polarization modulation of light, which is based on the Faraday effect [62] 
and is described in detail below. The system also utilizes Faraday rotation to compensate 
for the rotation due to glucose, which serves as a mechanism to provide feedback 
control, another fundamental aspect of this research.   
  In this chapter, we describe the development of a dual wavelength optical 
polarimeter utilizing real-time closed-loop feedback control to ultimately overcome 
corneal birefringence. At first, the system was characterized in vitro using a birefringent 
plastic cuvette, and the performance of the system is measured against an open-loop 
system. Later, the sample cuvette was replaced by eye phantoms, which include a plastic 
eye model (in vitro) and isolated corneas from New Zealand White (NZW) rabbits (ex 
vivo). Finally, the system was applied in vivo on anesthetized NZW rabbits.  
 
Materials and Methods 
Dual Wavelength Polarimeter 
The optical configuration of our dual wavelength system is based on a set of crossed 
polarizers, a modulating Faraday rotator, and dual Faraday compensators used for 
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closing the loop. As depicted in Figure 20, the optical sources are two laser diode 
modules (Power Technology Inc.) at wavelengths of 635 nm and 830 nm emitting at 7 
mW and 20 mW, respectively. The 830-nm laser was later replaced by a 532-nm diode-
pumped solid-state laser. The output light is polarized (1:100,000) by employing Glan-
Thompson linear polarizers (Newport). Both the beams then pass through respective in-
house built Faraday rotators which act as rotation compensators and are present only for 
closed-loop operation. The design and working principle of these active devices are 
described in detail in the following section. The two beams are then made coincident 
using a beam splitter/combiner (Optosigma Corp.). The polarization vector is modulated 
using a modulating Faraday rotator at 1.09 kHz with modulation depth of ~ ± 1 degree. 
The light then passes through a moving birefringent sample, a moving plastic cuvette 
with glucose doped water solutions in the physiological range of 0 to 600 mg/dl. For ex 
vivo experiments, the cuvette is later replaced by the eye respective eye phantoms. The 
motion of the sample is controlled using a computer-programmable translation stage 
(Thorlabs). Following the sample is another linear polarizer, which is oriented 
perpendicular to the initial polarizers and acts as an analyzer. The two beams are then 
separated using a combination of beam splitter and band-pass filters at individual 
wavelengths. The detection is provided by two photodiodes (Thorlabs), followed by 
respective wide-bandwidth amplifiers (Melles-Griot). Phase-sensitive detection is 
provided by two lock-in amplifiers (Stanford Research Systems). These signals serve as 
inputs to a digital controller programmed in LabVIEW 8.5 (National Instruments). The 
controller is essentially a proportional-integral-derivative (PID) controller providing 
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real-time closed-loop feedback. The output of the PID controller is connected to the 
respective Faraday compensators via a driver circuit. 
 
 
 
 
 
Figure 20. Experimental setup of the dual-wavelength optical polarimeter. Note that the 
sample holder can either be a plastic cuvette, the plastic ocular phantom or the artificial 
anterior chamber phantom for fixing isolated corneas. The two ports on the top of the 
eye coupling device are used to fill in the tube with PBS solution in order to accomplish 
index matching.  P, polarizer; FC, Faraday compensator; BS, beam-splitter; FM, Faraday 
modulator; PD, photodetector; LIA, lock-in amplifiers. 
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The operation of this system is described by the following equation [20]: 
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where I is the intensity of the detected signal, θm is the angular modulation depth 
provided by the modulating faraday rotator, ωm is the modulation frequency, and φ is the 
rotation due to the optically active sample. It follows from Equation (3) that without an 
optically active sample and with the DC term removed, the detected signal consists only 
of the double frequency (2ω) term. When the optically active sample is introduced, the 
detected signal becomes an asymmetric sinusoid, which contains both the fundamental 
(ω) and the double frequency components. 
In the case of a glucose sample with no birefringence, the φ term represents 
rotation only due to glucose and hence the glucose concentration can be measured 
directly by the feedback provided to close the system loop. However, in the case of a 
birefringent sample, the φ term includes both optical activity and rotation due to 
birefringence. This makes the extraction of change due to glucose in the presence of 
birefringence impossible by using a single wavelength approach, unless some type of 
birefringence compensation is utilized. To overcome this problem, our system utilizes 
two separate wavelengths in order to compensate for the effect of birefringence which is 
observed for both the wavelengths. 
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Control System 
In past, a combination of simple proportional control and linear scanning for closed-
loop polarimetry has been utilized [20, 91], whereby the output of the control system is 
the input multiplied by a user-defined calibration factor and then a small range of 
voltages were scanned to ultimately null the system. Although effective for a slower 
moving birefringence, the dynamic response of such a system would not be adequate for 
in vivo studies. Here we compare the performance of a closed-loop system with an open-
loop system using dual wavelengths. In the case of the open-loop system, the total gain 
of the system is fixed and is dependent mainly on the system electronics. Also, due to 
the open-loop nature of this process, the output is not observable by the system and 
hence the system is incapable of rejecting any disturbances. For the closed-loop case, we 
have utilized a PID control mechanism to stabilize our feedback system and to provide 
optimal dynamic response. Although the use of proportional feedback control can reduce 
the error due to disturbances in the system, a constant input can still result in non-zero 
steady-state error. A common way of eliminating such error is to add a controller term 
proportional to the integral of the error. This virtually eliminates this error since the 
integral term is the sum of all past values of the error. In our current polarimetric system, 
the disturbance originates due to variation in birefringence of the sample. Inclusion of an 
integrator usually deteriorates the dynamic response of the system. This is overcome by 
addition of a differentiator to the control system which significantly improves the 
dynamic response.  The PID gain parameters were optimized using Ziegler-Nichols 
tuning rules [92]. In this method, the conditions for adjusting the PID parameters are 
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based on estimating the amplitude and frequency of oscillations of the system at the 
point of marginal stability. In general, the controller settings according to Ziegler-
Nichols rules provide acceptable closed-loop response for most systems.  
 
Faraday Rotators 
The Faraday rotators, used for both modulation and compensation, consist of 1-cm 
long Terbium-Gallium-Garnet (TGG) crystals (Deltronic Crystals, Inc.) inside electrical 
coils. TGG crystals were employed since it is one of the highest Verdet-constant 
magneto-optic materials commercially available and the optical losses involved therein 
are lower than that of other high Verdet-constant materials. The solenoid is made up of 
~3500 turns of 30 gauge magnetic wire around a custom-machined bobbin made out of 
Delrin, a commonly available engineering thermoplastic. A low power audio amplifier is 
utilized to provide the modulation signal to the Faraday coil which is connected in serial 
to a 0.1 μF capacitor in order to achieve resonance at the modulation frequency of 1.09 
kHz. For compensation, a simple operational amplifier driver circuit was used.  
     
Eye Coupling Mechanism 
An in-house built eye coupling device, shown in Figure 21, was used to couple light 
in and out of the anterior chamber of the eye phantom. The device consists of an inverted 
glass tube with four 1-cm reflecting prisms (Thorlabs, Newton, NJ) attached in a 
periscope configuration. The glass tube is filled with phosphate buffered saline (PBS) 
solution which allows for index-matched coupling through the mounted ex vivo corneas, 
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and resulted in a straight path through the anterior chamber while minimizing beam 
divergence and deflection [93]. The presence of PBS solution also kept the cornea 
hydrated and helped reduce epithelium degradation [68]. 
 
 
 
 
Figure 21. Photograph (left) and CAD model (right) of the eye coupling device.  The 
glass test tube can be filled with PBS solution to allow for index-matched coupling 
through the isolated corneas clamped on the artificial anterior chamber phantom. 
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Plastic Eye Model 
For in vitro operation, a custom-built ocular eye model (Ocular Instrument Inc., 
Bellevue, WA) was used to mimic the anterior chamber of the eye. As shown in Figure 
22, the anterior chamber of the eye was retrofitted with 0.5 mm infusion tubes. This 
modification allowed changing the glucose concentration in the anterior chamber. The 
cornea is made out of Poly (methyl methacrylate) (PMMA) which has a refractive index 
of 1.489. The relative index mismatch between the refractive indices of PMMA and PBS 
(n = 1.33) did not allow for perfect index matched coupling using the above mentioned 
eye coupling device. Instead, the anterior chamber was immersed in a large glass cuvette 
(Starna Cells, Inc., Atascadero, CA) filled with PBS. The index mismatch resulted in a 
slight deviation of the beam leaving the anterior chamber relative to the input beam and, 
therefore, the detection side of the optical system had to be adjusted accordingly. 
Finally, the eye was mounted on a programmable translation stage to induce motion 
artifact. 
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Figure 22. Photograph of the custom-built ocular model. Note that the chamber is fitted 
with two infusion tubes, which allows changing of glucose concentration in the anterior 
section. 
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Ex Vivo Mounted Corneas 
Corneas (n = 3) were harvested from New Zealand White rabbits. All corneas were 
visually inspected, and were visibly transparent before, during and after the ex vivo 
measurements. Excised corneas with 2-3 mm of scleral rim were mounted on an 
artificial anterior chamber (Katena Products, Denville, NJ) as shown in Figure 23. The 
base of the chamber comes fitted with two ports to inflate the anterior chamber, which 
were used to change the glucose concentration in the anterior chamber of the eye. The 
hydrostatic pressure within the chamber was maintained at the intra ocular pressure level 
of 15 ± 0.1 mmHg. Similar to the plastic eye phantom, the mount to hold the artificial 
chamber was fitted on a translation stage to achieve motion artifact. 
 
 
 
Figure 23. Photograph of an isolated cornea clamped on the artificial anterior chamber. 
Note that the clamping region is within the sclera which can minimize stress on cornea. 
 62 
In Vivo Animal Studies 
Three New Zealand White rabbits (Harlan, Indianapolis, IN) weighing 2.27 kg to 2.50 
kg were used. The anesthesia regimen was formulated by mixing the 9 ml Ketamine 
(100mg/ml), 3 ml Acepromazine (10mg/ml) and 1.8 ml L. A. Rompun (100 mg/ml) in 
7.2 ml of saline solution. The resultant cocktail was administered intramuscularly at the 
rate of 1 ml per 1.5 kg body weight. After anesthesia, the rabbits were placed on an 
adjustable platform underneath the eye coupling device, as shown in Figure 24-25. The 
coupling device was then lowered slowly over the rabbit’s eye until contact was made. 
The inverted glass tube was then filled with saline solution to accomplish index 
matching at the corneal interface. Placing a rubber o-ring coated with an eye hydration 
ointment helped seal the gap and minimized fluid leakage. 
Initially, complete blood analyses were performed to measure the blood glucose 
levels during anesthesia. This is important since the xylazine in anesthesia is known to 
have a strong hyperglycemic effect due to its blocking of the pancreatic insulin release 
through stimulation of parasympathetic receptors [94, 95]. Consequently, the content of 
glucose in the aqueous humor is increased considerably. While, such behavior can be 
regarded as the inducing factor for cataractous changes seen in animals with a low 
tolerance to high glucose levels in aqueous humor, the effect is desirable for in our 
animal study. The anesthesia regimen serves a dual purpose of working as a bolus 
injection of glucose, otherwise difficult to induce in rabbits without diabetes. During the 
course of the experiment, 1-ml blood samples were withdrawn every ~10 minutes and 
were analyzed using both a hand-held blood glucose meter (Accu-Chek Aviva system) 
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and the YSI 2300 glucose analyzer. These measurements provided useful information 
related to trends in the blood glucose levels which potentially correlate to aqueous 
humor glucose levels. 
 
 
 
 
Figure 24. Photograph of the eye coupling device. Note that the double periscope 
configuration allows for a direct light path through the eye which, otherwise, would be 
blocked by rabbit’s facial features. 
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Figure 25. Photograph of the eye coupling device placed on the rabbit eye. Note that the 
test tube is filled with saline solution to allow for index matching. 
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Results and Discussion 
In Vitro Experiments using Glucose Samples in a Cuvette 
For open-loop operation, the system was first calibrated without motion using simple 
linear regression. This provides the conversion factors required to convert the measured 
signal at the lock-in amplifier to the respective glucose concentrations. This was 
followed by validation experiments, repeated four times on a moving birefringent 
sample cuvette.  The glucose concentration was varied in the physiologic range of 0 to 
600 mg/dl in 50-mg/dl steps. Simple linear regression was applied to the data for 
individual wavelengths.  Figures 26 and 27 show estimated glucose concentration as a 
function of the actual glucose concentration. It is evident that a single wavelength open-
loop system at either wavelength is incapable of estimating glucose concentration in a 
test cell with time-variant birefringence. For instance, the mean error in prediction of 
glucose was calculated to be 186.9 mg/dl and 185.6 mg/dl, with R2-values of 0.149 and 
0.166, respectively. This calculated value of error in glucose estimation is an average of 
errors in glucose estimation for four individual sets. It does not take into account the 
effect of using a single calibration model to validate separate data sets, the effect of 
which can be seen as the extent of error bars in Figures 26 and 27 which are an order of 
magnitude larger than the mean error in glucose estimation. This variation between data 
sets and thus the lack of repeatability is a result of the open-loop nature of the system, 
which makes it unfeasible to use a single calibration model for validation. Hence these 
error bars signify both the error due to time variant birefringence and due to the lack of 
repeatability from other noise disturbances. To see the effect of utilizing dual 
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wavelengths, the combined dual wavelength data was used in a multiple-linear 
regression analysis. The mean error in prediction of glucose was calculated to be slightly 
less at 181.8 mg/dl with R2-value of 0.516. As shown in Figure 28, the magnitude of 
error bars is also noticeably less but the open-loop system is still incapable of estimating 
glucose concentrations in the physiologic range. 
 
 
 
Figure 26. Mean estimated glucose concentration as a function of actual glucose 
concentration for an open-loop single wavelength model using the 635 nm wavelength. 
Error bars represent variation between four separate experiments and are quite high as 
anticipated for this system in the presence of variable birefringence and other noise 
disturbances not compensated in an open-loop system. 
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Figure 27. Mean estimated glucose concentration as a function of actual glucose 
concentration for an open-loop single wavelength model using the 830 nm wavelength. 
Error bars represent variation between four separate experiments and are quite high as 
anticipated for this system in the presence of variable birefringence and other noise 
disturbances not compensated in an open-loop system. 
  
 68 
 
Figure 28. Mean predicted glucose concentrations for the real-time open-loop dual 
wavelength system using a multi-regression model. Error bars represent variation 
between four separate runs of experiments. Note that the open-loop dual wavelength 
system significantly reduced the magnitude of the error bars compared to single 
wavelength system but they are still much too high for physiologic monitoring due to 
other noise disturbances not compensated by the open loop system.    
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The system was then calibrated for closed-loop operation followed by validation 
experiments, again repeated four times. The feedback loops for both wavelengths were 
closed in near real-time simultaneously using two separate PID controllers programmed 
in LabVIEW. The data acquisition time was set to be ~ 500 ms which was just over the 
time taken by the control mechanism to stabilize the system. Figures 29-30 show the 
predicted glucose concentration as a function of actual glucose concentration for the 
closed-loop case. It is evident that the variation in between different data sets is reduced 
since the scale of error bars is an order of magnitude less when compared to open-loop 
single-wavelength system (Figures 26 and 27). However, this is not enough to accurately 
determine sample glucose concentration. The mean error in estimation of glucose was 
calculated to be 164.6 mg/dl and 131.6 mg/dl, with mean R2-values of 0.566 and 0.355 
for 635 nm and 830 nm wavelengths, respectively. This result demonstrates the problem 
of how the change in the birefringence of the sample cloaks the optical rotation due to 
glucose. To compensate for the effect of this birefringence, the single wavelength data 
for both the wavelengths was used in a MLR analysis. As shown in Figure 31, this 
analysis considerably increased the overall linearity of the collected data - mean R2-
value of 0.996 - and reduced the mean error in estimation of glucose to 12.8 mg/dl. The 
application of multiple-linear regression is analogous to scaled subtraction. The general 
idea is to use this regression analysis to predict the contribution of birefringence to the 
total rotation of state of polarization. The data points for both wavelengths are used to 
calculate optimal weights for respective data sets. Once these coefficients are 
determined, the sample noise can be removed by subtracting the scaled data sets. The 
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overall result is reduction in the effect of time-varying birefringence due to motion 
artifact which manifests as sample noise for both the wavelengths. 
 
 
 
 
Figure 29. Mean estimated glucose concentration as a function of actual glucose 
concentration for a closed-loop single wavelength model using the 635 nm wavelength. 
Error bars represent variation between four separate experiments.  Note that the closed-
loop single wavelength system cannot accommodate for the time-varying birefringence. 
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Figure 30. Mean estimated glucose concentration as a function of actual glucose 
concentration for a closed-loop single wavelength model using the 830 nm wavelength. 
Error bars represent variation between four separate experiments.  Note that the closed-
loop single wavelength system cannot accommodate for the time-varying birefringence. 
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Figure 31. Mean predicted glucose concentrations for the real-time closed-loop dual 
wavelength system using a multi-regression model. Error bars represent variation 
between four separate runs of experiments.  Note that the dual wavelength real-time PID 
closed-loop system can be used to accommodate time-varying birefringence. 
 
 
These results demonstrate the advantages of using a closed-loop system over an open-
loop system, and the dual-wavelength system compared to the single-wavelength system 
for the case of time varying birefringence. By the way of theoretical background, closed-
loop systems are much more efficient in rejecting disturbances [92]. They are also less 
sensitive to random fluctuations in operating conditions which makes them less 
susceptible to noise. Previously reported optical polarimetric techniques have utilized 
feedback based on scan–based algorithms [24, 30], which have intrinsically slow 
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dynamic response for zero steady-state error. Our proposed approach utilizes dual 
wavelength, near real-time, feedback using PID control. The use of real-time feedback is 
important since the ultimate application of this technique is to reduce the effect of time-
variant corneal birefringence in the eye. 
 
In Vitro Experiments using Plastic Ocular Phantom 
The results of the dual wavelength polarimetric system for determining glucose 
concentration inside the anterior chamber of the plastic eye phantom are presented in 
Figures 32–33. The experiment was also repeated four times across the physiologic 
glucose concentration range. Figure 32(a) and 32(b) show the single-wavelength 
polarimetric measurements for 635-nm and 532-nm wavelengths, respectively. As 
anticipated, these results indicate that a linear model based on a single wavelength is 
unable to predict glucose concentration in presence of motion artifact. As mentioned 
earlier, such a system is unable to differentiate between the rotation due to optical 
activity of glucose and due to the time varying birefringence. The mean standard error of 
prediction of glucose concentration is 113.5 mg/dL and 136.5 mg/dL for the 
wavelengths of 635 nm and 532 nm, respectively. However, when the measurements 
from individual single wavelengths are treated with multiple linear regression (MLR) 
analysis, the effect of birefringence is significantly reduced as shown in Fig. 33. The 
dual wavelength system response is much more linear in comparison to either individual 
wavelength response and the mean standard error of prediction is reduced by an order of 
magnitude to 14.5 mg/dL with a correlation coefficient of 0.998.  
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Figure 32. Mean estimated glucose concentration as a function of actual glucose 
concentration for the in vitro single wavelength model using (a) 635-nm, and (b) 532-nm 
wavelengths. Note that the error bars represent the variation between four separate 
experiments and are large, showing the inability of a single wavelength model to predict 
glucose concentration. 
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Figure 33. Mean estimated glucose concentration as a function of actual glucose 
concentration for the in vitro dual wavelength model. The error bars represent the 
variation between four separate experiments and are significantly reduced relative to the 
single wavelength models. 
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Ex Vivo Experiments using Isolated Corneas 
While the application of dual wavelength polarimetry to in vitro glucose sensing in 
the plastic eye model serves to demonstrate how this method may be applied in vivo, 
physiologic sample noise conditions due to actual corneal birefringence as well as the 
refractive index difference between cornea (1.376) and the polymer (1.489) are 
somewhat different. Therefore, we extended the application of our approach to isolated 
corneas mounted on an artificial eye anterior chamber. Since our eye coupling 
mechanism allows the light to travel straight through the anterior chamber, without 
interacting with any ocular tissues other than the cornea, the isolated corneas more 
closely represent physiologic conditions. Although, clamping corneas at the scleral rim 
can create artificial boundary conditions which can potentially affect corneal 
birefringence, the clamping geometry of the artificial chamber in our phantom 
minimized the stress on the sclera [96]. 
The results of our polarimetric approach for determining glucose concentration inside 
the corneas clamped on an artificial anterior chamber are presented in Figures 34–35. 
Similar to the in vitro results, a single wavelength system using either wavelength is 
unable to predict the glucose concentration ex vivo with required precision. The mean 
standard error of estimation is calculated to be 125.4 mg/dL and 151.1 mg/dL for the 
individual wavelengths of 635 nm and 532 nm, respectively. However, when the 
information from both the wavelengths is combined and analyzed using MLR, the error 
in estimation is reduced significantly to a mean value of 22.4 mg/dL and appeared much 
more linear with a correlation coefficient of 0.996. This further demonstrates the 
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potential of the dual-wavelength approach to compensate for the time varying corneal 
birefringence. 
 
 
 
 
Figure 34. Mean estimated glucose concentration as a function of actual glucose 
concentration for the ex vivo single wavelength model using (a) 635-nm, and  (b) 532-
nm wavelengths. Note that the error bars represent the variation between three separate 
experiments and are large, showing the inability of a single wavelength model to predict 
glucose concentration. 
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Figure 35. Mean estimated glucose concentration as a function of actual glucose 
concentration for the ex vivo dual wavelength model. The error bars represent the 
variation between three separate experiments and are significantly reduced relative to the 
single wavelength models. 
 
 
 
It was noted that the noise in measurement signal was slightly more pronounced in the 
case of ex vivo cornea experiments in comparison to in vitro plastic phantom 
experiments, and is evident by the sensitivity of the system in the respective 
experiments. We believe that one of the major factors contributing to this relatively 
reduced accuracy is the corneal tissue compliance. Although, the clamping of the cornea 
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approximates the in vivo environment, changing the glucose concentration in the 
artificial anterior chamber results in a pressure cycle. This behavior has been previously 
studied in detail by Boyce et al. [97]. In their constrained inflation experiments, it was 
observed that the viscoelastic behavior of cornea generated hysteresis in the pressure-
deformation response at the apical region. Such behavior can physically move the region 
on cornea being probed by the laser beam, during and in between measurements, 
resulting in a long-term drift in the polarimetric signal. We quantified this sample noise 
by determining the variation within and across signal measurements. As mentioned 
above, each measurement is based on a ten-point running average. The standard 
deviation within these ten points in a single measurement, in terms of glucose 
concentration, was found out to be similar (~ 6 mg/dL) for both in vitro plastic phantom 
and ex vivo cornea phantom measurements. In contrast, the standard deviation of ten 
disparate measurements taken at one-minute time intervals was relatively higher for ex 
vivo isolated cornea measurements (~ 65 mg/dL) when compared to that for in vitro 
plastic phantom measurements (~ 17 mg/dL). This corneal hysteresis type of response in 
the ex vivo cornea phantom experiments represents an artificial added noise source and 
the biomechanical response in vivo will clearly be much less pronounced since the intra 
ocular pressure variation is controlled physiologically and is limited to a much smaller 
range in the normal eyes. 
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In Vivo Experiments in Rabbits 
In order to gain an understanding of the hyperglycemic effect of xylazine, blood 
glucose measurements were done every five to ten minutes. Such a response for three 
different rabbits is shown in Figure 36. As can be seen, while the absolute values 
somewhat differ, all the rabbits exhibit the same general trend in blood glucose levels 
after the administration of anesthesia. The glucose levels tend to rise to over twice the 
initial levels and plateau around 55 – 60 minutes. These observations serve as a 
reference for polarimetric glucose measurements. 
 
 
 
Figure 36. Blood glucose response in NZW rabbits after administration of anesthesia 
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The first run of polarimetric studies was performed to verify the operation of the eye 
coupling mechanism, and to test whether the light can be successfully coupled and 
transmitted through the anterior chamber of eye. In all the experiments to date, the 
coupling device has performed remarkably well in terms of coupling light through the 
anterior chamber of the eye. The beams at two different wavelengths follow an 
overlapping path throughout the device and the eye, and the output beams stay 
coincident at the detector input. 
In order to ascertain the source of motion artifact in the detected signal, a portion of 
the feedback signal as a function of time was decomposed into its constituent 
frequencies using fast Fourier transform (FFT). Ideally, such a treatment should produce 
a DC value only, since the lock-in amplifier outputs a DC value proportional to the 
amplitude of the signal of interest. The frequency domain signal for both the 
wavelengths is shown in Figures 37 and 38 for two separate runs. In both the instances, 
the largest peak other than at DC occurs near 1.0 – 1.1 Hz range, and correlates well in 
between both the wavelengths. The variation in signal at this frequency is believed to be 
due to the motion artifact caused by the breathing cycle. The frequency of respiration i.e. 
breaths per minute in a NZW rabbit anesthetized using the 
ketamine/xylazine/acepromazine anesthesia can vary between 40 to 90 breaths per 
minute, and somewhat varies as a function of time since administration of anesthesia 
[98]. The peak near 0 Hz is due to the average value of time series signal. Other possible 
sources of motion artifact, including the cardiac cycle which occurs at 3-4 Hz, noticed 
previously [22] were not observed in this analysis.  
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Figure 37. Spectral analysis of the time-based polarimetric feedback signal – Run 1; top: 
635-nm feedback, bottom: 532-nm feedback. 
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Figure 38. Spectral analysis of the time-based polarimetric feedback signal – Run 2; top: 
635-nm feedback, bottom: 532-nm feedback. 
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Polarimetric glucose measurements were then performed in vivo using the dual-
wavelength system. The single wavelength measurements are shown in Figure 39 and 
Figure 40 for the two individual wavelengths. The standard error in prediction of glucose 
concentration was calculated to 10 mg/dL and 7 mg/dL for the 635-nm and 532-nm 
single wavelength models, respectively. While these calculated error values are better 
than that of in vitro and ex vivo results, it should be noted that this estimation is over a 
much smaller glucose level change, which is approximately 33 mg/dL across the four 
data points. A percentage error is, therefore, a better indicator of the system sensitivity. 
The error values calculated above translate to ~30% and ~20% error for the 635-nm and 
532-nm single wavelength models, respectively. Now, when the data from individual 
wavelengths is treated with MLR, the overall error is reduced to 6% (~2 mg/dL), as 
shown in Figure 41, demonstrating the potential of our approach to account for the time 
varying corneal birefringence due to eye motion artifact. Additional studies similar to the 
previous were performed with error in glucose estimation varying from 5% to 12%. 
 Although, the calculated errors seem quite low in terms of physiological glucose 
levels, a complete characterization of this technique would require varying blood 
glucose levels over a much larger range. At any rate, this investigation of optical 
polarimetry for glucose sensing shows considerable promise, and future work towards 
more robust eye coupling mechanism and sophisticated control systems can potentially 
improve the current design towards the ultimate development of a noninvasive glucose 
sensor. 
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Figure 39. Predicted glucose concentration as a function of actual glucose 
concentration for the single wavelength model using the 635-nm wavelength. 
 86 
 
 
 
 
Figure 40. Predicted glucose concentration as a function of actual glucose concentration 
for the single wavelength model using the 532-nm wavelength. 
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Figure 41. Predicted glucose concentration as a function of actual glucose concentration 
for the dual wavelength model. Note that the overall error in estimation of glucose is 
now reduced to 6% in comparison to 30% and 20% for 635-nm and 532-nm single 
wavelength models, respectively. 
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CHAPTER V  
CONCLUSIONS AND FUTURE WORK 
 
In summary, the goal of this research was to design and develop a noninvasive 
optical polarimetry technique to ultimately measure the glucose concentration in the 
anterior chamber of the eye as a means to ascertain blood glucose concentration.  
The first part of this study was focused towards understanding and characterization 
of the corneal birefringence properties in the eye under both matched and unmatched 
refractive index conditions. The change in the light propagation and state of polarization 
of transmitted light were both modeled and experimentally measured. The corneal 
birefringence was shown to vary significantly as a function of both position and angle of 
incidence, but regions of relatively minimal net change were also observed. It was 
demonstrated that change in the polarization vector due to corneal birefringence is at 
least an order of magnitude larger than that due to the change in optical path length and 
glucose concentration. Experimental observations ascertain the validity of our theoretical 
framework towards modeling of peripheral corneal birefringence and, although the 
absolute values did not exactly match the model, the relative values were consistent 
between the experiments and model. Both the modeling and experiments showed the 
potential of using a dual-wavelength polarimetric approach towards measuring the 
aqueous humor glucose concentration as means to minimize the corneal birefringence 
noise and thus quantify blood glucose concentration. Overall, the knowledge gained 
from these experiments and modeling can be useful in understanding changes in 
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polarized light as it traverses an eye and will provide a framework for building an index-
unmatched coupling system toward the ultimate development of an optical polarimeter 
for noninvasive in vivo glucose sensing. 
The latter part of the dissertation focuses on design and development of a real-time 
optical polarimetric approach for glucose sensing utilizing two wavelengths. The use of 
second wavelength along with real-time feedback enabled the reduction of the effect of 
time-variant birefringence. This significantly enhanced the sensitivity of the system in 
the presence of motion artifact thereby reducing the error in glucose estimation by an 
order of a magnitude compared to a single wavelength model and compared to the open-
loop dual wavelength model. The application of the system was then extended to probe 
glucose in a realistic plastic eye model and ex vivo using New Zealand White rabbits’ 
corneas mounted on a pressurized artificial anterior chamber. The results demonstrate 
that the dual wavelength optical polarimetric approach can accurately determine the 
glucose concentration in the presence of time varying corneal birefringence due to 
motion artifact in the eye. Finally, the animal studies performed on the NZW rabbits 
indicate that the system has the potential for in vivo glucose sensing. 
Future work should focus on creating higher speed feedback algorithms for in vivo 
studies in order to accommodate for potential saccadic eye movements which occur at a 
rate that is an order of magnitude faster than the motion artifact due to the respiratory 
and the cardiac cycles. The speed of the system can also be potentially enhanced by 
using faster modulation schemes. The current modulator design limits the modulation 
frequency to a few kHz. Improved modulator design which can tolerate higher 
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modulation frequencies may allow for faster demodulation mechanisms, thereby, 
decreasing the time taken by the control system to reach stability. 
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